Home Carboxes 6684-06-6
6684-06-6,MFCD05664916
Catalog No.:AA00FA3S

6684-06-6 | 2-Chloropyridine-3-sulfonyl chloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$26.00   $18.00
- +
5g
95%
in stock  
$42.00   $30.00
- +
100g
97%
in stock  
$833.00   $583.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00FA3S
Chemical Name:
2-Chloropyridine-3-sulfonyl chloride
CAS Number:
6684-06-6
Molecular Formula:
C5H3Cl2NO2S
Molecular Weight:
212.0538
MDL Number:
MFCD05664916
SMILES:
Clc1ncccc1S(=O)(=O)Cl
Properties
Computed Properties
 
Complexity:
223  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
1  
XLogP3:
1.8  

Downstream Synthesis Route

[1]Karpina,VeronikaR.;Kovalenko,SvitlanaS.;Kovalenko,SergiyM.;Drushlyak,OleksandrG.;Bunyatyan,NatalyaD.;Georgiyants,VictoriyaA.;Ivanov,VladimirV.;Langer,Thierry;Maes,Louis[Molecules,2020,vol.25,#19]

[2]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/42860,2009,A1Locationinpatent:Page/Pagecolumn33

[3]Postovskii,I.Ya.;Kotovskaya,S.K.;Mokrushina,G.A.;Il'enko,V.I.;Platonov,V.G.;Polonyankin,A.V.[PharmaceuticalChemistryJournal,1980,vol.14,#2,p.123-127][Khimiko-FarmatsevticheskiiZhurnal,1980,vol.14,#2,p.50-54]

[1]CurrentPatentAssignee:LANXESSAG-US6365780,2002,B1Locationinpatent:Pagecolumn6-7

[2]Lebegue,Nicolas;Gallet,Sebastien;Flouquet,Nathalie;Carato,Pascal;Pfeiffer,Bruno;Renard,Pierre;Léonce,Stéphane;Pierré,Alain;Chavatte,Philippe;Berthelot,Pascal[JournalofMedicinalChemistry,2005,vol.48,#23,p.7363-7373]

[3]Locationinpatent:experimentalpartHogan,PhilipJ.;Cox,BrianG.[OrganicProcessResearchandDevelopment,2009,vol.13,#5,p.875-879]

[4]Andricopulo,AdrianoD.;Caljon,Guy;Campbell,Simon;Chelucci,RafaelC.;Dessoy,MarcoA.;Dias,LuizC.;Ferreira,LeonardoL.G.;Koovits,PaulJ.;Kratz,JadelM.;Maes,Louis;Matheeussen,An;Michelan-Duarte,Simone;Mowbray,CharlesE.[2020,vol.11,#11]

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2007/60623,2007,A1Locationinpatent:Page/Pagecolumn24

[6]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2336107,2015,B1Locationinpatent:Paragraph0309

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/109643,2018,A1Locationinpatent:Page/Pagecolumn101;159

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;OTSUKAHOLDINGSCOLTD-WO2018/109649,2018,A1Locationinpatent:Page/Pagecolumn78

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/109647,2018,A1Locationinpatent:Page/Pagecolumn115;263

[10]CurrentPatentAssignee:SINOCHEMHOLDINGSCORPORATIONLTD;Syngenta(in:SinochemHoldings)-US5866568,1999,A

[11]Francotte,Pierre;Nørholm,Ann-Beth;Deva,Taru;Olsen,Lars;Frydenvang,Karla;Goffin,Eric;Fraikin,Pierre;DeTullio,Pascal;Challal,Sylvie;Thomas,Jean-Yves;Iop,Fabrice;Louis,Caroline;Botez-Pop,Iuliana;Lestage,Pierre;Danober,Laurence;Kastrup,JetteS.;Pirotte,Bernard[JournalofMedicinalChemistry,2014,vol.57,#22,p.9539-9553]

1122-58-3    6684-06-6    89464-87-9   
2-chloro-N-(3-methoxy-5-methylpyrazin-2-yl)pyridine-3-sulphonamide 

[1]Patent:US5866568,1999,A

[1]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.5035-5040

[1]CurrentPatentAssignee:SOSEIGROUPCORPORATION-WO2014/6402,2014,A1Locationinpatent:Page/Pagecolumn93

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:6684-06-6 Molecular Formula|6684-06-6 MDL|6684-06-6 SMILES|6684-06-6 2-Chloropyridine-3-sulfonyl chloride